mlkrborn Thursday, 06/21/12 12:57:41 PM Re: None Post # of 1222 Accuray announced it is on track to meet or exceed integration success metrics and expecting near-term return to profitability (ARAY) 5.97 : As part of Accuray's transformative acquisition of TomoTherapy Incorporated on June 10, 2011, the co set forth success metrics. In addition to reiterating the co's plans to return to profitability by the end of fiscal year 2013, which ends June 30, 2013, Accuray provided additional milestones for its fiscal year 2013. These included enhanced revenue growth, beyond the maintained or modestly increased revenue the co committed to for fiscal 2012. Specific guidance for fiscal year 2013 will be announced during Accuray's earnings call for the results for 4th quarter of fiscal 2012, but the co intends to focus on maximizing product sales through continued product innovation and market penetration. Co also anticipates further service gross margin improvements reaching 20-22 percent for the full fiscal year 2013, which is higher than originally announced.